25 years International Bladder Cancer Network (IBCN): The past, the present, and the future
- 25 November 2022
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 41 (7) , 302-306
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Toward noninvasive follow-up of low-risk bladder cancer – Rationale and concept of the UroFollow trial*Urologic Oncology: Seminars and Original Investigations, 2020
- A Consensus Molecular Classification of Muscle-invasive Bladder CancerEuropean Urology, 2020
- Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer networkUrologic Oncology: Seminars and Original Investigations, 2018
- Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelinesUrologic Oncology: Seminars and Original Investigations, 2016
- Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non–muscle-invasive bladder cancer?—An International Bladder Cancer Network projectUrologic Oncology: Seminars and Original Investigations, 2016
- Follow-up in non–muscle-invasive bladder cancer—International Bladder Cancer Network recommendationsUrologic Oncology: Seminars and Original Investigations, 2016
- Considerations on the use of urine markers in the management of patients with high-grade non–muscle-invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2014
- Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non–muscle invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2014
- ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular MarkersEuropean Urology, 2013
- p53 immunohistochemistry in bladder cancer—a new approach to an old questionUrologic Oncology: Seminars and Original Investigations, 2010